The Regulatory Affairs Professional Society (RAPS) has posted an informative article “After Three-Year Delay, FDA Finalizes Guidance Documents on Biosimilarity.” The article includes links to the final guidance documents. You can find the article here.
The post FDA Finalizes Biosimilar Guidance appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.